SCHEMBL4483729

SCHEMBL4483729

COC(=O)c1cc(C)c2cc(Br)ccc2n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.57
HTT P42858 2/20 0.48
TSHR P16473 1/20 0.48
GAA P10253 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MAPT P10636 2/20 0.46
CYP1A2 P05177 1/20 0.46
RECQL P46063 1/20 0.46
CASP3 P42574 2/20 0.45
ATM Q13315 1/20 0.44
KMT2A Q03164 1/20 0.44
NR4A2 P43354 1/20 0.43
TP53 P04637 1/20 0.43
ABCG2 Q9UNQ0 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
MMP8 P22894 1/20 0.43
MMP13 P45452 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12571906 0.88 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2L3MBTL1HTTTSHR
SCHEMBL1999627 0.86 ALDH1A1 (0.78) ALDH1A1SMN1; SMN2L3MBTL1HTTGAA
SCHEMBL17769119 0.85 L3MBTL1 (0.57) ALDH1A1SMN1; SMN2L3MBTL1HTTTSHR
SCHEMBL16832230 0.85 L3MBTL1 (0.72) ALDH1A1SMN1; SMN2L3MBTL1HTTTSHR
SCHEMBL28121717 0.84 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2L3MBTL1HTTGAA
SCHEMBL28100530 0.84 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2L3MBTL1HTTTSHR
SCHEMBL22396163 0.84 L3MBTL1 (0.56) ALDH1A1SMN1; SMN2L3MBTL1HTTTSHR
SCHEMBL17205286 0.84 L3MBTL1 (0.59) ALDH1A1SMN1; SMN2L3MBTL1HTTTSHR
SCHEMBL28563581 0.83 GRM2 (0.52) ALDH1A1SMN1; SMN2L3MBTL1HTTTSHR
SCHEMBL16914925 0.82 TDP1 (0.47) ALDH1A1SMN1; SMN2L3MBTL1HTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7592358-B2 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-09-22 US disclosed
US-20050234101-A1 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234101-A1 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds MCHR1, GPR119, MCHR2 ALDH1A1 3567/4885SMN1; SMN2 2309/4885L3MBTL1 1955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.